Dose-dependent effect of angiotensin II on human erythropoietin production

Pflugers Archiv European Journal of Physiology

Volumn 439, Issue 6, 2000, Pages 838-844

  Freudenthaler, Stefan M ^a   Lucht, Ilka ^a   Schenk, Tim ^a   Brink, Marijke ^c   Gleiter, Christoph H ^a,b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c NONE

Author keywords

Angiotensin II; Erythropoietin; Healthy volunteers; Insulin like growth factor I (IGF I)

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ERYTHROPOIETIN; LOSARTAN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ERYTHROPOIESIS; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BINDING;

EID: 0034026280     PISSN: 00316768     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004249900238     Document Type: Article

References (30)

1. 1. Fisher JW, Samuels AI, Langston JW (1967) Effects of angiotensin and renal artery constriction on erythropoietin production. J Pharmacol Exp Ther 157:618-625
2. 2. Freudenthaler SM, Schenck T, Lucht I, Gleiter CH (1999) Fenoterol stimulates human erythropoietin production via activation of the renin angiotensin system. Br J Clin Pharmacol 48:631-634
3. 3. Freudenthaler SM, Schreeb KH, Körner T, Gleiter CH (1999) Angiotensin II increases erythropoietin production in healthy human volunteers. Eur J Clin Invest 29:816-823
4. 4. Gleiter CH (1996) Posttransplant erythrocytosis: a model for the investigation of the pharmacological control of renal erythropoietin production? Int J Clin Pharmacol Ther 34:489-492
5. 5. Gleiter CH, Freudenthaler S, Delabar U, Eckardt KU, Mühlbauer B, Gundert-Remy U, Osswald H (1996) Erythropoietin production in healthy volunteers subjected to controlled hemorrhagia: evidence against a role of adenosine. Br J Clin Pharmacol 42:729-735
6. 6. Gleiter CH, Becker T, Wenzel J (1997) Erythropoietin production in healthy volunteers subjected to controlled hypobaric hypoxia: further evidence against a role for adenosine. Br J Clin Pharmacol 44:203-205
7. 7. Gleiter CH, Becker T, Schreeb KH, Freudenthaler S, Gundert-Remy U (1997) Fenoterol but not dobutamine increases erythropoietin production in humans. Clin Pharmacol Ther 61:669-676
8. 8. Gleiter CH, Schreeb KH, Goldbach S, Herzog S, Cunze T, Kuhn W (1998) Fenoterol increases erythropoietin concentrations during tocolysis. Br J Clin Pharmacol 45:157-159
9. 9. Gould AB, Goodman S, DeWolf R, Onesti G, Swartz C (1980) Interrelation of the renin system and erythropoietin in rats. J Lab Clin Med 96:523-534
10. 10. Gunga HC, Wittels P, Günther T, Kanduth B, Vormann J, Röcker L, Kirsch K (1996) Erythropoietin in 29 men during and after prolonged physical stress combined with food and fluid deprivation. Eur J Appl Physiol 73:11-16
11. 11. Herkens C, Wolff M, Fandrey J, Schuler F, Jelkmann W (1993) Immunocytochemical demonstration of erythropoietin in hypoxic hepatoma cultures. Histochemistry 100:303-309
12. 12. Jackson EK, Garison JC (1996) Renin and angiotensin. In: Hardman JG et al. (eds) Goodman and Gilman's the pharmacological basis of therapeutics, 9th edn. Mc Graw-Hill, New York, pp 733-758
13. 13. Jelkmann W, Metzen E (1996) Erythropoietin in the control of red cell production. Ann Anat 178:391-403
14. 14. Jilma B, Krejcy K, Dirnberger E, Eichler HG, Kapiotis S, Dorner GT, Wagner OF (1997) Effects of angiotensin II infusion at pressor and subpressor doses on endothelin 1 plasma levels in healthy men. Life Sci 60:1859-1866
15. 15. Karlberg BE, Tolagen K (1977) Relationships between blood pressure, age, plasma renin activity and electrolyte excretion in normotensive subjects. Scand J Clin Lab Invest 37:521-528
16. 16. Klaassen RJ, van Gelder T, Rischen-Vos J, Deinum J, Man in't Veld AJ, Weimar W (1997) Losartan, an angiotensin II receptor antagonist, reduces hematocrits in kidney transplant recipients with posttransplant erythrocytosis. Transplantation 64: 780-782
17. 17. Klausen T, Dela F, Hippe E, Galbo H (1993) Diurnal variations of serum erythropoietin in trained and untrained subjects. Eur J Appl Physiol 67:545-548
18. 18. Kurtz A, Zapf J, Eckardt KU, Clemons G, Bauer C (1988) Insulin-like growth factor-1 stimulates erythropoiesis in hypophysectomized rats. Proc Natl Acad Sci USA 85:7825-7829
19. 19. Maxwell PH, Osmond MK, Pugh CW, Heryet A, Nicholls LG, Tan CC, Doe BG, Ferguson DJ, Johnson MH, Ratcliffe PJ (1993) Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 44:1149-1162
20. 20. McDonald KM, Taher S, Aisenbrey G, De Torrente A, Schrier RW (1975) Effect of angiotensin II and an angiotensin II inhibitor on renin secretion in the dog. Am J Physiol 228:1562-1567
21. 21. Mrug M, Stopka, T, Julian BA, Prchal JF, Prchal JT (1997) Angiotensin II stimulates proliferation of normal early erythroid progenitors. J Clin Invest 100:2310-2314
22. 22. Ohtawa M, Takayama F, Saitoh K, Yoshinaga T, Nakashima M (1993) Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans. Br J Clin Pharmacol 35:290-297
23. 23. Paekh N, Zou AP (1996) Role of prostaglandins in renal medullary circulation: response to different vasoconstrictors. Am J Physiol 271:F653-F658
24. 24. Pals DT, Couch SJ (1993) Renin release induced by losartan (DuP 753), an angiotensin II receptor antagonist. Clin Exp Hypertens 15:1-13
25. 25. Pasqualetti P, Casale R (1997) No influence of aging on the circadian rhythm of erythropoietin in healthy subjects. Gerontology 43:206-209
26. 26. Pratt MC, Lewis Barned NJ, Walker RJ, Bailey RR, Shand BI, Livesey J (1992) Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers. Br J Clin Pharmacol 34:363-365
27. 27. Torregrosa JV, Campistol JM, Montesinos M, Rogada AG, Oppenheimer F, Andreu J (1994) Efficacy of captopril on posttransplant erythrocytosis. Long-term follow-up. Transplantation 58:311-314
28. 28. Vlahakos DV, Balodimos C, Papachristopoulos V, Vassilakos P, Hinari E, Vlachojannis JG (1995) Renin-angiotensin system stimulates erythropoietin secretion in chronic hemodialysis patients. Clin Nephrol 43:53-59
29. 29. Wide L, Bengtsson C, Birgegard G (1989) Circadian rhythm of erythropoietin in human serum. Br J Haematol 72:85-90
30. 30. Wolff M, Jelkmann W (1992) Clinical applicability of the determination of erythropoietin. In: Pagel H, Weiss CH, Jelkmann W (eds) Pathophysiology and pharmacology of erythropoietin. Springer, Berlin Heidelberg New York, pp 99-107